Bisphenol A (BPA) is an estrogenizing endocrine disruptor compound of concern. Our objective was to test whether lifelong BPA would impact cardiac structure/function, calcium homeostasis protein expression, and the DNA methylation of cardiac genes. We delivered 0.5 and 5.0 µg/kg/day BPA lifelong from gestation day 11 or 200 µg/kg/day from gestation day 11 to postnatal day 21 via the drinking water to C57bl/6n mice. BPA 5.0 males and females had increased body weight, body mass index, body surface area, and adiposity. Echocardiography identified concentric remodeling in all BPA-treated males. Systolic and diastolic cardiac functions were essentially similar, but lifelong BPA enhanced male and reduced female sex-specific differences in velocity of circumferential shortening and ascending aorta velocity time integral. Diastolic blood pressure was increased in all BPA females. The calcium homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation. Changes in their expression suggest increased calcium mobility in males and reduced calcium mobility in females supporting the cardiac function changes. DNA methyltransferase 3a expression was increased in all BPA males and BPA 0.5 females and reduced in BPA 200 females. Global DNA methylation was increased in BPA 0.5 males and reduced in BPA 0.5 females. BPA induced sex-specific altered DNA methylation in specific CpG pairs in the calsequestrin 2 CpG island. These results suggest that continual exposure to BPA impacts cardiac structure/function, protein expression, and epigenetic DNA methylation marks in males and females.
The potential for estrogenizing endocrine disruptor compounds (EDCs) to have a negative impact on human and wildlife health has become a concern. The Developmental Origins of Health and Disease hypothesis has linked changes in the nutritional environment such as dietary protein restriction or changes in the physiological environment such as hypertension of the pregnant mother with negative growth effects on the fetus (Barker et al., 2007) . In some instances, an increase in the incidence of chronic diseases that include cardiovascular disease was found in the adult progeny (Barker et al., 2007; Kemp et al., 2012) . These data link altered nutrition or physiology during fetal development to increased cardiovascular disease in the adult. The fetus is also exposed to the mother's chemical environment. In utero and early life exposure to various manmade compounds eitherprescribed or in the environment is widespread. Analysis of the urinary profile of pregnant women in the National Health and Nutrition Examination Survey (NHANES) 2003 (NHANES) -2004 cohort demonstrated the near ubiquitous presence of many man-made compounds, including the estrogenizing EDC bisphenol A (BPA) (Woodruff et al., 2011) . Human exposure to BPA is thought to be mainly from ingestion of contaminated food and beverages but can also be from nonfood and nonoral sources such dermal absorption from thermal paper and possibly other avenues such as air and dust (Geens et al., 2012) . Importantly, exposure to BPA continues beyond the uterine period, may be greater in young children and adolescents than in adults, and continues lifelong (Vandenberg, 2011) .
Rodent studies have identified a negative impact for BPA and other EDCs on fertility, reproduction (male and female), and behavior and an increase in the risk for obesity and diabetes (Migliarini et al., 2011; Walker and Gore, 2011; Wolstenholme et al., 2012) . At least some of these effects were inherited to succeeding generations. This transgenerational effect was linked to increases in the DNA methyltransferase expression and the transmission of epigenetic changes in altered DNA methylation. Whether EDCs have any impact on other organ systems and activities is only beginning to be explored. Recently, BPA was shown to increase systolic blood pressure (Cagampang et al., 2012) , alter the heart beat in isolated heart preparations from females and not males (Yan et al., 2011) , blockade the sodium channel receptor although at supraphysiological doses (O'Reilly et al., 2012) , and alter cardiac calcium homeostasis via plasma membrane estrogen receptor stimulation in isolated female heart preparations (Belcher et al., 2012) . Human and rodent hearts are comparable in that they develop similarly, express functional estrogen and androgen receptors, and respond to cardiac insults and programming with similar phenotypes (Buckingham et al., 2005; Sizarov et al., 2011) .
To test the hypothesis that exposure to estrogenizing EDCs could impact cardiac function, we treated the drinking water of pregnant C57bl/6n dams with vehicle (VEH) or doses of BPA calculated to deliver BPA at 0.5 and 5.0 µg/kg/day and continued treatment of the progeny until 4 months. Another group was treated with drinking water to deliver BPA 200 µg/kg/day during gestation and lactation. We characterized growth, reproductive organ weights, organ fat deposits, cardiac structure/ function, expression of calcium homeostasis proteins critical for cardiac contraction and relaxation, and cardiac DNA methylation in adult female and male progeny.
MATERiALS AND METhODS
Animal manipulation. All mouse manipulation was reviewed by the Lady Davis Institute/Jewish General Hospital Animal Care Committee and performed according to the guidelines of the Canadian Council on Animal Care. All mice were fed Harlan Teklad Global 2018 diet and housed in standard cages with 1/4″ corn cob bedding in a 12-h dark and 12-h dark/light schedule throughout life. BPA (CAS 80-05-7, > 99% pure, Cat. No. 239658) was purchased from SigmaAldrich, Oakville, Ontario. C57BL/6n mice (Charles River, St Constant, Que) were mated, and the day of vaginal plug detection was labeled gestation day (GD)0.5. Assuming a constant drinking volume of 5 ml water/mouse/day, the glass-bottled drinking water of pregnant dams (n = 8/group) was treated with VEH or BPA calculated to deliver about 0.5 or 5.0 µg/kg/day BPA from GD11.5 until euthanasia. A separate group was treated with BPA calculated to deliver 200 µg/kg/day from GD11.5 until weaning as a positive control for effects such as longer anogenital distance (AGD). Once weaned the progeny of BPA 200 dams were treated with VEH water. The higher dose of BPA is four times the lowest observable adverse affect level suggested by the U.S. Environmental Protection Agency and the U.S. Food and Drug Administration.
Physiological parameters. AGD, body weight (BW), and body length (BL) measurements were collected at weaning and monthly until euthanasia at 4 months. BL was from the tip of the nose to the base of the tail. Measurements used calipers on isoflurane-anesthetized mice.
At euthanasia, AGD, BW, BL, tibia length (TL), and the wet weights of the heart (HW) and adipose deposits surrounding the kidneys, combined testes, combined ovary, and mesentery were collected. In addition, the weights of the uterus and combined ovary in females and the combined weight of the testes, all prostate lobes, and seminal vesicle including contents in males were collected. Hearts were immediately frozen and stored at −80°C.
Body mass index (BMI) was calculated using the formula BMI = [BW/(BL) 2 ] × 100, where BW is in grams and BL in cm. Body surface area (BSA) was calculated using the formula BSA = [K × (   3   √W   2 )], where K is the species specific constant for mice, and W is the BW in grams (Cheung et al., 2009) . BSA is the parameter used to compare heart size clinically and may better represent the size of the mouse because it incorporates a body shape component in the calculation. A schematic outlining the timing of the animal manipulations is shown in Figure 1 .
Cardiac function analyses. Echocardiography, at ~16 weeks of age, was performed using a rodent dedicated VEVO 770 ultrasonograph system and analyzed using proprietary software (VisualSonics, Toronto, Ontario). Mice were anesthetized with 3% isoflurane and 1.5 l/min air. Images were acquired and analyzed using standard views in murine echocardiography (Sebag et al., 2005 (Sebag et al., , 2011 Thibault et al., 2010) . Motion mode acquisitions were used to measure left ventricular (LV) dimensions and LV posterior wall and interventricular septal wall thickness. Pulsed-wave Doppler images were used to measure ascending aorta artery and pulmonary artery velocity time integrals, Ao VTI and PA VTI respectively, as indirect measurements of LV and right ventricle (RV) stroke volume. The Tissue Doppler Imaging cursor was positioned at the endocardium in the LV short-axis view, and endocardial velocity (Vendo) was measured to assess global systolic as validated previously (Sebag et al., 2005) . Moreover, the tissue Doppler-derived early diastolic velocity was also measured; this parameter has been validated as a parameter of LV relaxation in small animals (Prunier et al., 2002) and humans (Nagueh et al., 1997) . E′ and A′ waves could not be discriminated from each other in any mouse because of the high heart rate of the acquisitions (> 530 beats per minute on average), and thus, the height of E′ alone was used as a surrogate marker for diastolic function.
At ~15 weeks, tail cuff blood pressure of conscious mice was measured using a Hatteras MC-4000 blood pressure analysis system (Cary, NC). Mice were trained at the same time everyday for 3 days, and measurements were recorded on day 4 and 5. Blood pressure values were collected when the heart rate was between 500 and 700 beats per minute.
Protein expression analysis. Hearts, 40 mg of the apical ventricle heart, were homogenized in RIPA buffer (1% NP-40, 50mM Tris [pH 7.4], 0.5% deoxycholate, 159mM NaCl, 0.1% SDS; 10mM sodium metabisulfite, 1mM sodium vanadate, proteinase inhibitor cocktail and PhosSTOP [Roche, Indianapolis, IN] , and 1mM PMSF). Homogenates were kept on ice for 2 h and then clarified by centrifugation in the cold. Protein was measured using the Bradford Protein Determination Assay (Bio-Rad, Hercules, CA) against bovine serum albumin.
Protein expression was measured using a standard immunoblotting method. Proteins, (10 to 20µg), were separated using SDS-PAGE, electrophoretically transferred to Immobilon P membrane (Millipore, Bedford, MA) and the membranes stained with Ponceau S (Sigma-Aldrich, St Louis, MO). Membranes were blocked and then incubated in the cold with specific antisera. Primary antibodies to NCX1 (Abcam Inc., Cambridge, MA; ab6495, 1:1000 dilution); SERCA2a (Santa Cruz Biotechnology, Santa Cruz, CA; N19 sc-8095, 1:1000 dilution); cardiac calsequestrin 2 (CASQ2, Abcam Inc.; ab626662, 1:2500 dilution); phospholamban (PLB, Thermo Scientific, Nepean, Ontario;
FiG. 1. Schematic of experimental design. Singly-caged pregnant C57bl/6n dams, n = 8 per treatment, were treated with drinking water to deliver BPA at 0.5 µg/kg/da, (BPA 0.5), 5.0 µg/kg /day, or 200 µg/kg/day from GDday 11.5. These calculations assumed that 5 ml/day of water would be consumed. Pups were weaned on day 21. Mice treated with BPA 200 were then switched to untreated water, whereas all others remained on BPA treatment. BW, BL, and AGD were collected monthly. Cardiac function tests were performed in the last 2 weeks prior to euthanasia at 4 months. DNA methylation. Genomic DNA, from n = 5 animals per group, was purified from ventricle tissue by high salt extraction and ethanol precipitation. Global DNA methylation was measured using a MethylFlash ELISA kit (Methylated DNA Quantification Kit, Epigentek Group Inc., NY). Methylated DNA standards and mouse DNA were applied to the ELISA plate, and the protocol was followed according to the manufacturers' instruction. A standard curve was generated from methylated DNA solutions and mouse DNA methylation quantitated in comparison with the standard curve. In silico analysis of the mouse cardiac CASQ2 gene (AC166072) using MethylPrimer software revealed a CpG island containing 9 CpG pairs ~ 1100 bps upstream of the CASQ2 transcription start site. Aliquots of genomic DNA isolated from ventricle heart were sent to EpigenDx, Worcester, MA. Bisulfite was used to treat the DNA, and the treated DNA was amplified with CASQ2 promoterspecific primers identified using the CASQ2 AC166072 DNA sequence and MethylPrimer software. The products were subjected to pyrosequencing to identify the per cent DNA methylation of individual CpG pairs.
Statistical analyses: Densitometry and standardization. Exposed x-ray films were scanned with a CanoScan 4200F (Canon). Protein quantification was determined using Image J software (NIH) by calculating the areas under the peaks of each band on the x-ray film in comparison with the area of scanned proteins on the Coomassie Brilliant Blue stained membrane. Expression in the VEH male group was arbitrarily assigned a value of 1.0. All groups were exposed to BPA or not during gestation and weaning so that all groups were compared at weaning. In adult mice, BPA 200 groups were only compared with VEH. The difference in exposure times between the BPA 200 group, which was exposed during gestation and lactation, and BPA 0.5 or BPA5.0 group, which was exposed lifelong, precludes direct comparison. Normality using the Kolmogorov-Smirnov test and equal variance about the group mean were passed prior to ANOVA analyses. Significance for all parameters was evaluated using two-way ANOVA with the statistical program SigmaStat 3.1 and the Student-Newman-Keuls post hoc test. Significance was also assessed by ANCOVA using litter size as a covariate and the Statistical Products and Services Solution version 20 statistical package. A p value of < 0.05 was considered significant.
RESuLTS

Impact of BPA on Growth
The time line of experimental handling is shown in the schematic in Figure 1 . We delivered BPA via the oral route to mimic a route of human exposure. We chose an exposure period beginning in mid-pregnancy with continuation lifelong to approximate the exposure of humans yet avoid the possibility for any adverse effects of BPA on implantation and very early development (Xiao et al., 2011) . At this early time point, GD11.5, the mouse heart is a functional four-chamber pump with all the major anatomical structures completed (Savolainen et al., 2009) .
We had no pups reported lost prior to weaning. There was no impact of treatment on litter size at weaning in VEH (7.3 ± 1.2), BPA 0.5 (7.3 ± 1.3), BPA 5.0 (7.3 ± 1.0), and BPA 200 (7.7 ± 1.2) treated dams.
At weaning, BPA 200 male and female pups had reduced BW compared with pups in all other groups, Table 1 . Despite this, BPA 200 male and female pups had increased AGD, AGD/ BW, and AGD/BL than VEH pups, increased AGD and AGD/ BL compared with BPA 0.5 pups, and increased AGD/BW compared with BPA 5.0 pups. In males, BMI and BSA were increased in BPA 5.0 compared with BPA 0.5 and BPA 200 pups. Regarding females, BPA 0.5 female pups had increased BW compared with VEH and BPA 5.0 pups. BPA 5.0 pups had increased BSA compared with BPA 200 pups. We conclude that high-dose BPA reduced body size and increased AGD in both male and female weanlings. Male BPA 5.0 pups were more affected than BPA 0.5 pups.
To determine whether BPA altered body size with time, we measured BW and BL monthly from weaning until 4 months and calculated BMI and BSA (Fig. 2) . In males, BPA 5.0 mice had greater BW, BMI, and BSA at 3 months than other male groups. In females, BPA 5.0 mice had greater BW and BSA compared with BPA 0.5 beginning at 3 months and greater BMI compared with VEH and BPA 0.5 at 4 months. BPA 200 males and females were smaller than VEH at 1 month. BPA 200 males were similar to VEH at 2 months. BPA 200 females remained 15. smaller than VEH mice at 3 months. We conclude that BPA 5.0 males and females had increased growth than other groups, and BPA 200 males displayed "catch-up" growth and reached normal size, whereas BPA 200 females remained smaller for longer period.
Impact of BPA on Cardiac Structure and Function
Echocardiography. To measure the impact of BPA on cardiac structure/function, we performed echocardiography and analyzed cardiac structure, Table 2 , and cardiac function, Table 3 , at 4 months.
All BPA-treated male mice had increased relative wall thickness (RWT) and no increase in left ventricle mass (LVM) compared with VEH mice. No structural differences were found in female mice. When males and females were compared, there were no sex differences in male and female VEH mice. In contrast, all BPA-treated female mice had reduced LVM and reduced LVM/BSA than their similarly treated male counterparts. BPA 5.0 females also had reduced RWT compared with BPA 5.0-treated males.
We detected no difference in the LV systolic function parameters Ao VTI, fractional shortening, velocity of circumferential shortening (Vcf) or Vendo, LV diastolic parameter E′ or RV parameter PA VTI within the male or female groups. However, when male and female mice were compared, we found increased E′ in all females versus all males regardless of treatment suggesting that this is a sex-specific parameter unaffected by BPA. In addition, BPA 0.5 female mice had reduced Vcf compared with BPA 0.5 males, and BPA 5.0 females had reduced Ao VTI compared with BPA 5.0 males. We conclude that BPA induced concentric remodeling, defined by convention as an increase in RWT without an increase in LVM, only in BPA males and induced additional sex-specific differences in LV cardiac structure and function not detected in comparisons with VEH males and females.
Blood pressure. To determine whether BPA induced an increase in blood pressure, we measured the systolic, diastolic, and mean arterial pressure, Table 4 . The kidney was also weighed because it is the major organ controlling blood CARDIAC RESPONSE TO BISPHENOL A volume and blood pressure. No differences were found in blood pressure values with BPA exposure in males, but BPA 5.0 males had reduced kidney weight compared with all other males. In females, systolic blood pressure was increased in BPA 5.0 compared with VEH. However, this small increase in systolic blood pressure did not reach 140 mmHg, which is considered to indicate hypertension in rodents, and so can be considered to be nonpathological. Diastolic and mean arterial pressures were significantly higher in all BPA-treated females compared with VEH females. When males and females were compared, systolic, diastolic, and mean arterial pressures were lower in VEH females than VEH males. However, no sex difference in blood pressure was detected when BPA males and BPA females were compared. We conclude that BPA had a sexspecific impact on blood pressure.
Impact of BPA on Physiological Parameters at Euthanasia
To determine the impact of BPA on cardiac physiological parameters, we measured HW, BW, BL, and TL at euthanasia at 4 months, calculated BMI and BSA, and indexed HW were also reduced in BPA 0.5 females compared with similarly treated males, BPA 5.0 females and males were similar. We conclude that BPA 5.0 reduced HW for size in males and removed sex-specific differences in HW indices.
To measure the impact of BPA on reproductive parameters, we measured AGD and the weights of sex-specific organs, Table 6 . In males, AGD did not differ. However, BPA 0.5 males had increased AGD/TL than VEH or BPA 5.0 males. BPA 200 males had increased AGD/TL compared with VEH males. Testes and seminal vesicle weights did not differ. The developing prostate is sensitive to estrogens, and so as expected and consistent with other studies (Timms et al., 2005) , prostate weight was increased with BPA. In females, no differences were found in AGD, AGD/TL, uterus, or ovary weights. We conclude that BPA affected male and not female reproductive organs.
To measure whether BPA altered adipose deposits, we weighed the adipose tissue surrounding the testes, ovary, kidney, and mesentery and calculated total fat, total fat/BW, and total fat/BSA, Table 7 . In males, perirenal fat, total fat, total fat/BW, and total fat/BSA were greater in all BPA versus VEH mice. In addition, BPA 5.0 males had increased mesenteric adiposity. In females, BPA 5.0 females had greater gonadal and mesenteric fat, total fat, total fat/BW, and total fat/BSA than VEH females. All females had less fat than similarly treated males. However, total fat/BW, which was unaffected by sex in VEH mice, was increased in all BPA males compared with BPA females. BPA 5.0 males and females had the greatest fat in all deposits. We conclude that BPA 5.0 increased adiposity independent of sex. Notes. Mice were euthanized at 4 months. Prostate is the combined weight of all four lobes; testes is the combined weight of both testes; seminal vesicles is combined weight of both lobes including contents; ovary is the combined weight of both ovaries and uterus. AGD and TL were measured using calipers. Data are expressed as mean ± SEM. Significance, p < 0.05, is indicated compared with 
Impact of BPA on Expression of SER Protein Expression
Cardiac function depends on the movement of calcium from the sarcoendoplasmic reticulum (SER) to the cytosol for contraction and from the cytosol back to the SER for relaxation with each beat (Goonasekera and Molkentin, 2012) . Calcium resequestration to the SER requires the activity of SERCA2a. SERCA2a activity is negatively regulated by binding to unphosphorylated PLB. Phosphorylation of PLB on serine-16 (pS 16 -PLB) and threonine-17 PLB (pT 17 -PLB) relieves this inhibition. The sodium calcium exchanger-1 (NCX1) removes cytosolic calcium to the extracellular space in exchange for sodium. Calsequestrin 2 (CASQ2) is the principle calcium storage protein in the SER. SERCA2a, NCX1, and CASQ2 expression is influenced by sex (Leinwand, 2003; Sebag et al., 2011) and in silico analysis has indicated putative estrogen response elements in their promoters.
To determine whether expression of these proteins is altered by BPA, we prepared ventricle heart homogenates and measured protein expression (Fig. 3) . In all BPA males, SERCA2a was increased, and PLB and phospho-PLB expression was unchanged. In addition, BPA 0.5 and 5.0 males had increased NCX1, and BPA 5.0 males had increased CASQ2 expression. BPA 200 males had increased CASQ2 expression in comparison with VEH males. Overall, the increased SERCA2a without a concomitant increase in its inhibitor PLB and increased NCX1 suggest a greater ability to remove calcium postcontraction, and the increased CASQ2 expression suggests an increase in the calcium storage capability in the SER in BPA males. In females, BPA 0.5 and BPA 5.0 mice had increased SERCA2a and PLB. Additionally, BPA 0.5 mice had increased NCX1, and BPA 5.0 mice had reduced CASQ2. pS 16 -PLB was reduced in BPA 200 females. The pattern, increased SERCA2a coupled to increased PLB and reduced pS 16 -PLB and reduced CASQ2, suggests the possibility for a reduction in the ability to remove calcium to the SER and a reduced ability to store calcium in BPA 5.0 mice. Notes. Mice were euthanized at 4 months. Gonadal fat is the total fat surrounding both testes or ovaries; perirenal fat is the total fat surrounding both kidneys; mesenteric fat is the fat in the peritoneal cavity; total fat is the sum of the organ fat deposits. Data are expressed as mean ± SEM. Significance, p < 0.05, is indicated compared with Thus, SERCA2a, NCX1, and CASQ2 expression was altered sex specifically with BPA exposure.
Impact of BPA on Cardiac DNA Methylation
BPA changes DNMT3a and DNMT3b expression and DNA methylation in reproductive tissues (Tang et al., 2012) . To determine whether BPA could influence DNA methylation in hearts, we measured the expression of DNMT3a and DNMT3b in heart homogenates (Fig. 4) . In males, all BPA mice had increased DNMT3a expression. In females, BPA 0.5 had increased DNMT3a expression. BPA 200 females had reduced DNMT3a and DNMT3b expression (Fig. 4A) .
To determine the impact of these DNMT expression changes, we extracted genomic DNA from ventricle heart and measured relative global DNA methylation (Fig. 4B) . In males, BPA 0.5 mice had increased global DNA methylation. In contrast and despite the increase in DNMT3a expression, BPA 0.5 females had reduced global DNA methylation.
Putative estrogen and estrogen-related receptor consensus binding sites and a CpG island are present in the mouse CASQ2 promoter sequence (Fig. 4C) . Previously, we showed that sex-and hormone-dependent CpG methylation is present in the CASQ2 CpG island (Sebag et al., 2011) . Ventricle heart DNA was treated with bisulphate, amplified with CASQ2 specific primers, and subjected to pyrosequencing (Fig. 4D) . In males, BPA 0.5 mice had increased DNA methylation at CpG pair 1 compared with BPA 5.0 and at CpG 4 compared with VEH and BPA 5.0. In addition, BPA 5.0 males showed reduced DNA methylation at CpGs 7, 8, and 9. In females, BPA 0.5 mice had increased DNA methylation at CpG pairs 7 and 8 compared with VEH, whereas BPA 5.0 mice had increased DNA methylation at CpG pair 6 compared with all other groups and increased CpG 7 DNA methylation compared with VEH. BPA 200 females had increased DNA methylation at CpGs 7 and 8 compared with VEH. We conclude that BPA exposure alters DNMT expression, global DNA methylation, and methylation within a cardiac-specific promoter differently with sex.
DiSCuSSiON
As expected, our study shows that lifelong exposure to BPA changed growth and increased adiposity. BPA also altered cardiac structure/function and directed sex-specific changes in calcium homeostasis protein expression. Further, we show sexspecific changes in cardiac DNA methylation, perhaps because of BPA-mediated changes in DNMT3a and DNMT3b expression. Some changes in cardiac structure/function, expression, and DNA methylation were present after exposure only during gestation and lactation. This implies permanence to some early BPA-induced changes. Some epidemiological studies found a correlation between patients with the highest levels of urinary BPA and worse cardiovascular disease (Bae et al., 2012; Lind and Lind, 2011; Melzer et al., 2012; Shankar et al., 2012) . However, a recent study using different inclusion criteria and more NHANES survey years found no association between high urinary BPA levels and heart attack or diabetes and has questioned the suitability of NHANES data for temporal and causal associations (LaKind et al., 2012) . Therefore, a role for BPA in cardiovascular disease remains unclear.
BPA Increased Growth and Adiposity
Lifelong BPA induced more growth and adiposity. BPA has induced greater fat deposits in mice (Richter et al., 2007; Rubin and Soto, 2009; vom Saal et al., 2012) . Concomitant with the increase in BW, BPA 5.0 increased BMI in males and increased adipose tissue in males and females even when indexed to BW or BSA. BL and TL did not differ, suggesting that the increases in BW, BSA, or BMI were not due to the induction of a larger mouse, but rather a heavier mouse. These data show predicted and consistent changes with BPA exposure in the male and female mice. HW and HW/TL changes with sex in mice are not well reported. Indexation to TL or BSA in mice is consistent with the type of indexation used in humans where LVM or HW is indexed to height or BSA but not solely to BW (Lang et al., 2005) . In the current study, all males had greater HW than all females when HW was indexed to BSA and TL and similar HW to females when HW was indexed to BW. Therefore, our data suggest greater HW in young male mice and that BPA does not affect this parameter.
We identified sex-specific responses to high-dose BPA. BPA 200 males, and not BPA 200 females, displayed "catch-up" growth. Further, fat and indexed adipose deposits were increased in BPA 200-exposed males compared with VEH males yet were similar in BPA 200-exposed and VEH females. Catch-up growth is associated with an increased risk for cardiovascular disease, suggesting that these BPA-exposed males, more so than their female littermates, might be prone to a detrimental cardiovascular outcome. These results suggest that both the response and consequences to BPA may be sex specific.
Cardiac Structure/Function Is Significantly Altered with
Lifelong BPA Exposure
Our echocardiograph data reveal sex-specific changes in cardiac structure/function. Male mice developed concentric remodeling, whereas cardiac structure in female mice was unaffected by BPA. The RWT increase was not the result of a pathological increase in blood pressure, leading to the idea that BPA directly acted upon heart structure. Indeed, BPA 5.0 females with a slight increase in systolic blood pressure had no increase in RWT. HW and HW/TL changes with sex in mice are not well reported. Indexation to TL or BSA in mice is consistent with the type of indexation used in humans where LVM or HW is indexed to height or BSA but not solely to BW (Lang et al., 2005) . In the current study, all males had greater HW than all females when HW was indexed to BSA and TL and similar HW to females when HW was indexed to BW. Therefore, our data suggest greater HW in young male mice and that BPA does not affect this parameter. The LV systolic function parameter Vcf was reduced in BPA 0.5 females, and the LV systolic function parameter Ao VTI was reduced in BPA 5.0 females compared with their male counterparts. This suggests that BPA mediated sex-specific changes in LV systolic function. The increased E′ in females when compared with males is suggestive of a more vigorous LV relaxation in the females. This is in fact consistent with better diastolic function in females versus males (Luczak and Leinwand, 2009) . Differences in LVM, LVM/BSA, and E′ were reflected in females regardless of the exposure time. This implies that the impact of BPA on heart structure once it occurs is long lasting and unaffected by BPA removal likely because cardiac structure formation is completed prior to birth.
An increase in systolic blood pressure to 112 mmHg accompanied by a reduction in kidney weight was found in adult male and female progeny of outbred MF-1 mice injected sc with 100 µg/kg/day BPA during gestation (Cagampang et al., 2012) . We found a reduction in kidney weight in BPA 5.0 male mice but did not detect a change in systolic blood pressure in males. The differences in mouse line (outbred MF-1 vs. inbred C57bl/6), route of exposure (sc vs. oral), and time of exposure (gestation only vs. lifelong) preclude a direct comparison. However, the reduction in kidney weight in both studies suggests that early BPA may impair kidney development in males. Impaired kidney function is often detected in hypertension. Together, the data suggest that BPA may impair kidney development, which might lead to an increased susceptibility to hypertension with age.
BPA Induced Changes in SER Calcium Homeostasis
BPA altered SERCA2a, NCX1, and CASQ2 expression in a sex-specific manner. In males, BPA-induced changes in their expression would be expected to increase calcium removal to the extracellular space and enhance stored calcium in the SER for contraction (Kučerová et al., 2012; Vandecaetsbeek et al., 2009) . The same pattern was not detected in females; rather the induced changes would likely lead to reduced calcium replacement into the SER in relaxation and reduced calcium for contraction in the SER. These expression changes correspond to the cardiac function differences where BPA-treated males have greater Vcf and Ao VTI than BPA-treated females. However, these results do not replicate the female-only effect of BPA seen in in vitro studies on isolated cardiomyocytes or isolated heart preparations (Belcher et al., 2012; Yan et al., 2011) . This is likely due to the long-term exposure and potential for compensatory events in our studies compared with the shorter exposure (minutes and hours) in the in vitro studies. In both males and females, we found significant changes in SERCA2a, NCX1, and CASQ2 when BPA exposure was limited to gestation and lactation, suggesting that continued exposure is not necessary to impact expression.
DNA Methylation Is Altered with BPA in Heart
BPA has nonmonotonic and sex-specific effects on cardiac DNMT3a expression and global DNA methylation and impacts DNA methylation at specific CpG pairs in the cardiac CASQ2 gene. BPA's impact on DNA methylation may be dose, tissue, developmental, and gene dependent. BPA has induced hypomethylation in phosphoesterase type 4 variant 4 and nucleosome binding protein-1 genes (Tang et al., 2012) , hypermethylation of the hippocalcin-like 1 gene (Tang et al., 2012) and gestational exposure decreased HoxA 10 DNA methylation (Bromer et al., 2010) . A genome-wide study of fetal brain after short-term BPA exposure identified opposing patterns of DNA methylation (Yaoi et al., 2008) . We found sex-specific altered DNMT expression and DNA methylation in mice exposed during gestation and lactation as well as those exposed lifelong.
The 11 exon mouse CASQ2 gene is on chromosome 2 (Zarain- Herzberg et al., 2012) . Cardiac CASQ2 expression depends on a ~3.2 kb upstream region, the transcription factors MEF2, Egr-1, and NFAT, and is modulated by methyl donor availability, sex and sex hormones, and gestational diethylstilbestrol (Haddad et al., 2013; Kasneci et al., 2009; Sebag et al., 2011) . We found reduced CASQ2 expression in mice fed folate-deficient diets (Sebag et al., 2011) and in H9c2 cells cultured with the DNMT inhibitor, 5-aza-deoxycytosine (Kasneci et al., 2009) . These data link changes in CASQ2 expression with altered one-carbon availability and reductions in DNA methylation.
In males, there was greater DNA methylation in the CASQ2 CpG island near its 5′ end in BPA 0.5 males and less methylation near the 3′ end in BPA 5.0 males. In BPA-treated females, all changes were present in the 3′ end of the CpG island. As was found in prostate (Tang et al., 2012) , BPA increased expression of DNMT3a in heart homogenates, suggesting that this is a common target and that DNMT3a is responsible for DNA hypermethylation. Although greater DNA methylation leads to reductions in transcription and expression when the CpG island overlaps the transcription start site, this paradigm may not be relevant for upstream CpG islands like the CASQ2 CpG island (Jones, 2012) . Previously, we found increased DNA methylation at CpG pair 3 mice correlated with reduced CASQ2 expression when 11-month-old retired breeder females were compared with similarly aged males (Sebag et al., 2011) . This pattern was not detected here in 4-month-old younger virgin females versus males. Rather, CpG 3 was similar, CpGs 7 and 8 DNA methylation was reduced, and CASQ2 expression was not reduced in females compared with males. Puberty was shown to influence the impact of neonatal BPA on prostate tissue DNA methylation (Tang et al., 2012) so it is conceivable that repeat pregnancy and/or the cardiac-specific changes that accompany the volume overload of pregnancy might change DNA methylation and expression.
CARDIAC RESPONSE TO BISPHENOL A
